| Title | whole genome sequencing |
|---|---|
| Description | Consolidative Nivolumab versus observation in Unresectable Stage III Non-Small Cell Lung Cancer Post Neoadjuvant Nivolumab plus Chemotherapy and Concurrent Chemoradiotherapy (CA209-7AL): A Randomized Clinical Trial |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA044113 |
| Release Date | 2025-08-04 |
| Submitter | Bo Qiu (qiubo@sysucc.org.cn) |
| Organization | Sun Yat-sen University Cancer Center |
| Submission Date | 2025-08-01 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX011275-01 | Genomic mutation data | 1 | Other Type of Genomic Data | 41.5 KB | xlsx | Unavailable |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|---|---|---|---|
| Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial | Signal Transduction and Targeted Therapy | 2025-09 | OMIX011275 | Deposit |